Heiko Zimmermann
Papers
4
Total Citations
79
H-Index
4
About
Dr. Heiko Zimmermann is a pioneering figure in cryobiology and cellular immunomonitoring, whose work bridges fundamental biopreservation science with clinical applications. His research centers on two interconnected domains: optimizing cryopreservation protocols for cell-based therapies and developing standardized, automated assays for immune function analysis. Zimmermann’s most impactful contribution, the 2016 study “Toward Optimal Cryopreservation and Storage for Achievement of High Cell Recovery and Maintenance of Cell Viability and T Cell Functionality” (46 citations), established critical parameters for preserving therapeutic cells without compromising their immunological activity. He further advanced the field through innovative micro-volume cryopreservation techniques, demonstrating that reducing sample volumes to 25 microliters significantly improves cell proliferation and differentiation outcomes. In parallel, Zimmermann has been instrumental in automating HIV vaccine research, developing a standardized pseudotyped virus production system (20 citations) and an automated ELISpot assay for safe, parallelized T cell analysis. These achievements have profound implications for global vaccine trials and cell therapy manufacturing, enabling reproducible, high-throughput immunomonitoring. His work exemplifies the convergence of cryobiology and clinical immunology, providing essential tools for translating cell-based therapies from bench to bedside.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4